PBS delisting triggers govt intervention on diabetes drug
The Federal Government says fast-acting insulin products Fiasp and Fiasp FlexTouch will be subsidised for patients with type 1 diabetes for an extra six months…
The Federal Government says fast-acting insulin products Fiasp and Fiasp FlexTouch will be subsidised for patients with type 1 diabetes for an extra six months…
The PBAC has recommended expanding the PBS listing for empagliflozin to include patients with chronic heart failure and a left ventricular ejection fraction above 40%.…
Leading doctors have clashed over eligibility criteria for COVID-19 antivirals — specifically nirmatrelvir–ritonavir — following claims many patients were being “short-changed” and left unprotected. Federal…
Semaglutide will return to pharmacy shelves this month, but the TGA has warned not all patients previously prescribed the GLP-1 receptor agonist will be able…
GPs can request COVID-19 antivirals for their Prescriber’s Bag, with the Federal Government swiftly implementing a PBAC recommendation from two weeks ago. But the government…
GPs may soon be able to dispense COVID-19 antivirals directly to their patients after the PBAC signed off on an RACGP proposal for a new…
For optimum impact, the agent needs to be initiated early while kidney function is relatively preserved, a specialist says.
Professor Joseph Proietto wants a 'serious discussion' about affordability of drugs for weight loss.
PBS prescribing software will not be updated with the expanded criteria until the start of next month.
The PBAC has agreed to a federal government request to expand eligibility.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.